Teneligliptin Hydrobromide Intermediate CAS 401564-36-1 Purity >99.5% (HPLC) Factory
Fana ka Teneligliptin Hydrobromide Tse Amanang le Li-Intermediate tse Nang le Bohloeki bo Phahameng
Teneligliptin Hydrobromide CAS 906093-29-6
1-(3-Methyl-1-Phenyl-5-Pyrazolyl)piperazine CAS 401566-79-8
Teneligliptin Hydrobromide ea Mahareng CAS 401564-36-1
| Lebitso la Lik'hemik'hale | (2S) -4-Oxo-2-(3-thiazolidinylcarbonyl) -1-pyrrolidinecarboxylic acid tert-butyl ester |
| Litlhaloso tse tšoanang | (S)-tert-Butyl 4-oxo-2-(thiazolidine-3-carbonyl)pyrrolidine-1-carboxylate;3-((S) -1-tert-butoxycarbonyl-4-oxo-2-pyrrolidinylcarbonyl) -1,3-thiazolidine;(2S) -4-oxo-2- (1,3-thiazolidin-3-ylcarbonyl)pyrrolidine-1-carboxylate;Teneligptin ea Hare B |
| Nomoro ea CAS | 401564-36-1 |
| Nomoro ea KAtse | RF-1818 |
| Boemo ba Setoko | Ka Setokong, Sekhahla sa Tlhahiso Ho fihlela ho Lithane |
| Foromo ea limolek'hule | Setšoantšo sa C13H20N2O4S |
| Boima ba Molek'hule | 300.37 |
| Botenya | 1.305 |
| Brand | Ruifu Chemical |
| Ntho | Tekanyetso ea Tlhahlobo | Liphetho |
| Ponahalo | 'Mala o Mosoeu ho isa ho Cream | Ikamahanye |
| Boitsebiso | IR;HPLC RT | Ikamahanye |
| Tahlehelo ka ho Omisa | <1.00% | 0.20% |
| Lintho Tse Amanang | Tšilafalo efe kapa efe e le 'Ngoe <0.50% | 0.24% |
| Tšilafalo Kakaretso <0.50% | 0.39% | |
| Tlhahlobo | 99.5%~102.0% (Ka Motheo o Omisitsoeng) | 99.8% |
| Enantiomeric Bohloeki | >99.5% | 99.9% |
| Molora oa Sulfate | <0.20% | 0.02% |
| Tekanyetso ea Teko | Maemo a Khoebo | |
| Tšebeliso | Likahare tsa Teneligliptin Hydrobromide (CAS: 906093-29-6) | |
Sephutheloana: Botlolo, Aluminium foil bag, 25kg/Cardboard Drum, kapa ho ea ka tlhokahalo ea moreki.
Boemo ba polokelo:Boloka ka lijaneng tse koetsoeng sebakeng se phodileng le se omileng;Sireletsa leseli le mongobo
(2S) -4-Oxo-2- (3-thiazolidinylcarbonyl) -1-pyrrolidinecarboxylic acid tert-butyl ester (CAS: 401564-36-1) ke lipakeng tse sebelisoang ho lokisetsa dipeptidyl peptidase IV (DPP-IV) inhibitor, intermediates. ea Teneligliptin Hydrobromide (CAS: 906093-29-6).Teneligliptin ke DPP-4 inhibitor e ileng ea amoheloa Japane ka 2012 bakeng sa kalafo ea lefu la tsoekere la mofuta oa II.E ile ea sibolloa mme ea ntlafatsoa ke Mitsubishi Tanabe Pharma tlasa lebitso la khoebo la Tenelia®.Joalo ka li-inhibitors tse ling tsa DPP-4 tse rekisitsoeng, Teneligliptin e ile ea mamelloa hantle lithutong tsohle mme dosing ea QD e hlahisitse ketso ea nako e telele e thibelang DPP-4 le keketseho ea maemo a sebetsang a GLP-1, ka sekhahla se tlase haholo sa ho tsoa ha renal.
